The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
This article reviews data on the use of NGA LAIs in schizophrenia and discusses current issues from clinical and methodological perspectives.
Source: Current Treatment Options in Psychiatry - Category: Psychiatry Source Type: research
More News: Abilify | Clinical Trials | Forensic Medicine | Invega | Men | Occupational Health | Psychiatry | Risperdal Consta | Schizophrenia | Statistics | Study | Zyprexa